NewAmsterdam Pharma (NAMS) FCF Margin (2023 - 2026)
NewAmsterdam Pharma (NAMS) posted FCF Margin of -1061.71% for Q2 2026, down 864.49 percentage points from -197.23% a year earlier and down 53.75 percentage points from the prior quarter.
Powered by 
Analysis
NewAmsterdam Pharma (NAMS) FCF Margin (2023 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, FCF Margin at NewAmsterdam Pharma was -2018.28%, down 1824.08 percentage points year-over-year; for FY2025, it was -657.82%, down 308.33 percentage points from FY2024.
- Annual FCF Margin shows a three-year change of -665.99 percentage points (FY2022 to FY2025).
- In prior years, NewAmsterdam Pharma's FCF Margin was -349.49% in FY2024 (+652.94 pp), -1002.43% in FY2023 (-1010.60 pp) and 8.17% in FY2022.
- Quarterly FCF Margin has run from a low of -128046.88% in Q4 2025 to a high of -43.20% in Q3 2024 over five years.
- On a year-over-year basis, FCF Margin increased in five of the last eight quarters, with an average year-over-year change of -15940.71 percentage points.
- The strongest year-over-year quarter for FCF Margin in the past five years was Q4 2024, with a gain of 3825.69 percentage points; the weakest was Q4 2025, with a drop of 127753.39 percentage points.
- According to Business Quant data, FCF Margin for the three prior quarters was -1007.96% (Q1 2026), -128046.88% (Q4 2025) and -9428.45% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.82% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 18.33% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 26.96% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 43.05% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 34.72% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.70% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 44.00% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.01% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 30.39% |
| 10 | NewAmsterdam Pharma | 2.77 Bn | 2.77 Bn | - | -1,061.71% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,061.71% |
| Mar 31, 2026 | -1,007.96% |
| Dec 31, 2025 | -128,046.88% |
| Sep 30, 2025 | -9,428.45% |
| Jun 30, 2025 | -197.23% |
| Mar 31, 2025 | -1,225.12% |
| Dec 31, 2024 | -293.49% |
| Sep 30, 2024 | -43.20% |
| Jun 30, 2024 | -2,377.71% |
| Mar 31, 2024 | -3,924.84% |
| Dec 31, 2023 | -4,119.18% |
| Sep 30, 2023 | -1,597.59% |
| Jun 30, 2023 | -1,707.05% |
| Mar 31, 2023 | -369.34% |
API Access
NewAmsterdam Pharma FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=NAMS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "NAMS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=NAMS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();